The European Parliament adopted its first-reading position approving the provisional agreement with the Council on the new regulation of the European Chemicals Agency. The Agency becomes a Union body with legal personality, with its seat in Helsinki, and its objectives and tasks are clarified, particularly with regard to transparency. This text is the final result negotiated with the governments of the Union; they must still formally approve it before it becomes law.
The European Chemicals Agency (ECHA) was created in 2007 to manage the technical, scientific and administrative aspects of chemicals regulation (REACH). Over time, other sectoral legislation has entrusted it with new tasks. The adopted regulation aims to clarify its legal status, its seat and its tasks, and to strengthen the transparency of its activities. It brings together in a single text the rules applicable to the Agency and amends several sectoral regulations.
Status as a Union bodyThe Agency becomes a Union body with legal personality, with the broadest legal capacity recognised to legal persons under national law. It is represented by an Executive Director.
Seat in HelsinkiThe seat of the Agency is in Helsinki, Finland.
Broadened objectivesThe Agency contributes to the implementation of Union legislation on the hazards, risks, safe use and environmental sustainability of chemicals. It aims for a high level of protection of human health and the environment, including for vulnerable groups, while promoting the free movement of substances in the internal market and taking into account the specific needs of micro, small and medium-sized enterprises.
Promotion of non-animal methodsThe Agency promotes and strengthens expertise in the replacement of hazardous chemicals and the development of non-animal approaches and emerging methods.
Transparency of requestsThe Agency must publish on its website the requests it receives in the context of its technical and scientific support tasks, as well as requests for scientific opinions made by the European Parliament or a Member State, and regularly update the progress status of these requests.
Parliament adopted the text by 561 votes in favour, 13 against and 39 abstentions (electronic roll-call vote).
This regulation confirms the role of the European Chemicals Agency as an independent scientific reference for the risk assessment of chemicals in the Union. Citizens will benefit from better transparency on the requests addressed to the Agency and from a stronger commitment to non-animal methods. Businesses, in particular SMEs, will have their specific needs taken into account in the Agency's work. The text must still be formally approved by the Council before it enters into force.
Parliament approved the new regulation of the European Chemicals Agency by 561 votes for, 13 against and 39 abstentions. The Agency becomes a Union body with legal personality, its headquarters remain in Helsinki, and its objectives are spelled out: protection of health and the environment, including vulnerable groups, free movement of substances in the internal market, competitiveness, the needs of SMEs, promotion of non-animal methods. The Council must still formally approve the text.
The merit of the text is to bring together in a single regulation the status, headquarters and missions of an agency that since 2007 had accumulated tasks scattered across some ten sectoral laws. For a chemical SME, knowing who evaluates, who advises and who decides is a real gain in readability. Legal personality and headquarters in Helsinki change nothing in daily life, but they put an end to an ambiguity kept alive by successive texts.
Yet the clarity of the status says nothing about the workload. Article 4 piles up general missions: technical support, digital tools, international cooperation, research, public access to information, prevention of conflicts of interest, dialogue with stakeholders, annual training of staff and committees. Each addition is presented as self-evident. None is costed, none is tied to a new resource. An agency that must do everything with a given budget ends up arbitrating in silence, and it is the companies' files that wait.
Article 4, paragraph 6, requires the Agency to publish the requests it receives and to keep their progress status up to date. That is progress: an industrialist or an NGO will be able to see how long an evaluation stays in the queue. But publishing delays does not eliminate them. If the Agency lacks scientific staff, the dashboard will be impeccable and the file blocked. Transparency becomes an alibi when it replaces the requirement for results.
The real lever would be elsewhere: enforceable deadlines, an obligation to respond within a given time, and a mechanism making the Agency accountable for its delays before Parliament and the Council. The text prefers the shop window to the obligation. An approach based on accountability would have set binding deadlines and left member states the possibility of speeding up national procedures, rather than adding a layer of reporting.
An agency that publishes its delays does not eliminate them: it makes them visible, which is not the same thing as reducing them.
Parliament approved the new regulation of the European Chemicals Agency by 561 votes for, 13 against and 39 abstentions. The Agency becomes a Union body with legal personality, its headquarters remain in Helsinki, and its objectives are spelled out: protection of health and the environment, including vulnerable groups, free movement of substances in the internal market, competitiveness, the needs of SMEs, promotion of non-animal methods. The Council must still formally approve the text.
The merit of the text is to bring together in a single regulation the status, headquarters and missions of an agency that since 2007 had accumulated tasks scattered across some ten sectoral laws. For a chemical SME, knowing who evaluates, who advises and who decides is a real gain in readability. Legal personality and headquarters in Helsinki change nothing in daily life, but they put an end to an ambiguity kept alive by successive texts.
Yet the clarity of the status says nothing about the workload. Article 4 piles up general missions: technical support, digital tools, international cooperation, research, public access to information, prevention of conflicts of interest, dialogue with stakeholders, annual training of staff and committees. Each addition is presented as self-evident. None is costed, none is tied to a new resource. An agency that must do everything with a given budget ends up arbitrating in silence, and it is the companies' files that wait.
Article 4, paragraph 6, requires the Agency to publish the requests it receives and to keep their progress status up to date. That is progress: an industrialist or an NGO will be able to see how long an evaluation stays in the queue. But publishing delays does not eliminate them. If the Agency lacks scientific staff, the dashboard will be impeccable and the file blocked. Transparency becomes an alibi when it replaces the requirement for results.
The real lever would be elsewhere: enforceable deadlines, an obligation to respond within a given time, and a mechanism making the Agency accountable for its delays before Parliament and the Council. The text prefers the shop window to the obligation. An approach based on accountability would have set binding deadlines and left member states the possibility of speeding up national procedures, rather than adding a layer of reporting.
An agency that publishes its delays does not eliminate them: it makes them visible, which is not the same thing as reducing them.